The Medicines Discovery Catapult has launched a series of webinars covering the drug discovery process.
XenoGesis, who became a MDC CRO partner in 2019, has been invited to speak on two of the webinars.
Optimising the Compound – 2.00pm BST, Wednesday 13 May 2020
Richard Weaver, XenoGesis’ Founder and CEO, will be presenting on ‘optimising ADME and PK properties: common mistakes and how to identify and resolve the key issues.’
Understanding the PK/PD Relationship – 2.00pm BST, Wednesday 27 May 2020
Graham Trevitt, XenoGesis’ Chief Scientific Officer, will be presenting on ‘principles and modelling of pharmacokinetic and pharmacodynamic relationships.’
For details on how to register, and to find out more about these and all the webinars in the series, click here.